An official website of the United States government
Home
Name
Istodax
Alternate Names
FK 228
FK-228
FK228
FR 901228
FR-901228
FR901228
Romidepsin
Depsipeptide
Abbreviations
None
Category
Chemotherapy
Subcategory
Natural product--microorganism toxin
NSC Number
630176
Primary Site
Histology
None
Remarks
June 17, 2011: The FDA granted accelerated approval for an additional indication for Istodax (romidepsin) for treatment of peripheral T-cell lymphoma (PTCL) in patients who have received at least one prior therapy. Istodax is also approved for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.
Coding
This drug should be coded
